iCAD
iCAD Employees
16 people indexed:
-
Andrew H. Sassine
Chief Financial Officer, Arcturus Therapeutics
xj.k9fqwgp@726x431.wkl Sign up to see email03.vuy6w7u@p8bv3xl.2w4 Sign up to see email -
r052n8@klr7y7j.q1f Sign up to see email
-
z0zzjj@klkyjp3.6sx Sign up to see email
-
Dr. Hedvig Hricak, MD, PhD, Dr.h.cm
Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Professor of Radiology, Weill Cornell Medical College
yssl956.2n78bt.25.j05.jf.f.zn@4nz90ty.qyx Sign up to see email1j5ww39.3fxzsb.75.t9b.yu.j.79@021zy53.x0t Sign up to see email -
Dr. Rakesh Patel
Chief Executive Officer, Precision Cancer Care Specialists Medical Group
2jbbu46.049xj@0778jq2.7v9 Sign up to see email6bxu6j0.y36q4@9vvj6u4.399 Sign up to see email -
Emily F. Conant, MD, FSBI
Division Chief, Breast Imaging Vice Chair Faculty Development, Professor of Radiology at the Hospital of the University of Pennsylvania, Perelman School of Medicine
zz.79xq32.9v.k3zy@6w7zjww.pqw Sign up to see emailx4.9hlg4k.8q.xuwl@r35rk41.vy7 Sign up to see email -
zjjy6xx65y@43yhkhr.zkg Sign up to see email
-
h0z@suthnvv.spb Sign up to see email
-
Kathy Schilling, MD
Medical Director of Christine E. Lynn Women’s Health & Wellness Institute, Boca Raton Regional Hospital, Affiliate Assistant Professor of Clinical Biomedical Science, Florida Atlantic University, Charles E Schmidt College of Medicine
uw7j351zfr.t2@pb9ffzv.w1z Sign up to see emailqj4rfvf49u.y4@1fwpy1r.r49 Sign up to see email -
Linda Moy, MD, FISMRM, FSBI
Professor of Radiology, NYU Grossman School of Medicine, Center for Advanced Imaging Innovation and Research, Faculty, Vilcek Institute of Graduate Biomedical Sciences, Laura and Isaac Perlmutter Cancer Center
7j07.hz.54gh71.4kqp@5nhn2q7.w95 Sign up to see emailkq08.jn.wtpt6q.p7vp@qpng8kh.jg1 Sign up to see email -
Michael J. Doyle, FACHE
CEO and President, Spire Health
p7.1w816.s5x3r@nkvs541.151 Sign up to see email7s.rzxq6.1v1kp@1v5uswp.s5u Sign up to see email -
Per Hall, MD, PhD
Professor at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
ujr48.2q.vk1@t0frv14.ux9 Sign up to see emailr2rtu.wb.ysg@12zx31s.bbw Sign up to see email -
Robert Nishikawa, PhD, FAAPM, FSBI, FAIMBE
Professor of Radiology at the University of Pittsburgh, Director of Imaging Research Laboratory
u8z972gu0z.26q.yjgu3.903t.y1z528@t48784x.xt1 Sign up to see email593l6g438q.0lj.zvgjy.812y.94560j@tjj8qgg.4j2 Sign up to see email -
Stamatia Destounis MD, FACR, FSBI, FAIUM
Partner Radiologist, Elizabeth Wende Breast Care, Clinical Professor University of Rochester Imaging Sciences
klh84hqp70.jp.jw35.xgyk.y65x7@5z4g889.6jz Sign up to see emailh3p9kjq3p5.p1.yh4y.xxqy.41h26@vw4737g.q24 Sign up to see email -
Susan Wood, Ph.D.
Chief Executive Officer, VIDA Diagnostics
1jz8j.jt.k@xk4vujv.8xq Sign up to see emaillq6bu.v9.f@q80lkxb.z20 Sign up to see email -
2bp3j74xgsf@wz4z3sx.pps Sign up to see email
iCAD Company Information
iCAD provides a suite of AI-powered solutions designed to enhance the accuracy of breast cancer detection, density assessment, and risk evaluation. Among its offerings is the ProFound AI Risk tool, an image-based risk model for breast cancer screening. The company’s solutions are FDA cleared, CE marked, and Health Canada licensed, ensuring compliance with major regulatory standards. In addition to cancer detection, iCAD offers a Heart Health solution that assesses breast arterial calcifications to evaluate the risk of heart disease. iCAD partners with leading industry, research, technology, and advocacy organizations to improve cancer detection and patient care. With a global presence in over 50 countries, iCAD holds 45 patents and has conducted 51 clinical studies to advance its AI algorithms. The company’s AI technology has been trained on over 6 million images from 100 clinical sites and has analyzed over 40 million mammograms worldwide in the last five years.